BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19454668)

  • 21. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
    Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
    J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
    Cheng G; Yu A; Dee MJ; Malek TR
    J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Rel controls multiple discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells.
    Grigoriadis G; Vasanthakumar A; Banerjee A; Grumont R; Overall S; Gleeson P; Shannon F; Gerondakis S
    PLoS One; 2011; 6(10):e26851. PubMed ID: 22066012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.
    Rosenbaum M; Gewies A; Pechloff K; Heuser C; Engleitner T; Gehring T; Hartjes L; Krebs S; Krappmann D; Kriegsmann M; Weichert W; Rad R; Kurts C; Ruland J
    Nat Commun; 2019 May; 10(1):2352. PubMed ID: 31138793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl10 is required for the development and suppressive function of Foxp3
    Yang D; Zhao X; Lin X
    Cell Mol Immunol; 2021 Jan; 18(1):206-218. PubMed ID: 31595055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
    David L; Li Y; Ma J; Garner E; Zhang X; Wu H
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
    McCully RR; Pomerantz JL
    Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
    Lee AJ; Wu X; Cheng H; Zhou X; Cheng X; Sun SC
    J Biol Chem; 2010 May; 285(21):15696-703. PubMed ID: 20233721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
    Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
    Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.
    Nakaya M; Xiao Y; Zhou X; Chang JH; Chang M; Cheng X; Blonska M; Lin X; Sun SC
    Immunity; 2014 May; 40(5):692-705. PubMed ID: 24792914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
    Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
    J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.
    Qiao G; Li Z; Molinero L; Alegre ML; Ying H; Sun Z; Penninger JM; Zhang J
    Mol Cell Biol; 2008 Apr; 28(7):2470-80. PubMed ID: 18227156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
    Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
    J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex.
    Martin D; Galisteo R; Gutkind JS
    J Biol Chem; 2009 Mar; 284(10):6038-42. PubMed ID: 19112107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of TSC1/2 signaling complex reveals a checkpoint governing thymic CD4+ CD25+ Foxp3+ regulatory T-cell development in mice.
    Chen H; Zhang L; Zhang H; Xiao Y; Shao L; Li H; Yin H; Wang R; Liu G; Corley D; Yang Z; Zhao Y
    FASEB J; 2013 Oct; 27(10):3979-90. PubMed ID: 23882125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation.
    Molinero LL; Cubre A; Mora-Solano C; Wang Y; Alegre ML
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18529-34. PubMed ID: 23091043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A20 Restrains Thymic Regulatory T Cell Development.
    Fischer JC; Otten V; Kober M; Drees C; Rosenbaum M; Schmickl M; Heidegger S; Beyaert R; van Loo G; Li XC; Peschel C; Schmidt-Supprian M; Haas T; Spoerl S; Poeck H
    J Immunol; 2017 Oct; 199(7):2356-2365. PubMed ID: 28842469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor.
    Long M; Park SG; Strickland I; Hayden MS; Ghosh S
    Immunity; 2009 Dec; 31(6):921-31. PubMed ID: 20064449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.